Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Clinical Science (London, England : 1979)|May 27, 2022
Angiotensin receptors - affinitiy and beyondColin Sumners, Igor Maciel Souza Silva, U Muscha SteckelingsClinical Science (London, England : 1979)|November 19, 2020
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonistsU Muscha Steckelings, Colin SumnersTrends in Endocrinology and Metabolism: TEM|July 23, 2017
Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 ReceptorU Muscha Steckelings, Annette de Kloet, Colin SumnersClinical Science (London, England : 1979)|May 27, 2018
Neuroprotection via AT2 receptor agonists in ischemic strokeDouglas M Bennion, U Muscha Steckelings, Colin SumnersThe Canadian Journal of Cardiology|May 12, 2020
The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT2-ReceptorKasper B Assersen, Colin Sumners, U Muscha SteckelingsPeptides|December 24, 2023
Development of an automated, high-throughput assay to detect angiotensin AT2-receptor agonistic compounds by nitric oxide measurements in vitroIgor Maciel Souza-Silva, A Augusto Peluso, Christina Mortensen, et al.Acta Physiologica (Oxford, England)|January 17, 2025
Phosphoproteomics for studying signaling pathways evoked by hormones of the renin-angiotensin system: A source of untapped potentialIgor Maciel Souza-Silva, Victor Corasolla Carregari, U Muscha Steckelings, et al.Medicinal Research Reviews|June 14, 2017
Small-molecule AT2 receptor agonistsMathias Hallberg, Colin Sumners, U Muscha Steckelings, et al.Current Hypertension Reports|January 27, 2015
Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in strokeDouglas M Bennion, Emily Haltigan, Robert W Regenhardt, et al.Current Hypertension Reports|July 28, 2012
Impact of the AT(2) receptor agonist C21 on blood pressure and beyondSébastien Foulquier, U Muscha Steckelings, Thomas UngerPageof 16